Atlas Trials

Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Disease

Clinical trial NCT04828031 · COMPLETED

Trial details

NCT number
NCT04828031
Sponsor
Stanford University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease
Start date
2021-07-01
Primary completion
2023-07-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.